Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

E. Giovannetti, A. Erozenci, J. Smit, R. Danesi, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)103-122
JournalCritical Reviews in Oncology / Hematology
Volume81
Issue number2
DOIs
Publication statusPublished - 2012

Cite this

@article{c5125c072ac049c0bbb3fe0263215604,
title = "Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice",
author = "E. Giovannetti and A. Erozenci and J. Smit and R. Danesi and G.J. Peters",
year = "2012",
doi = "10.1016/j.critrevonc.2011.03.010",
language = "Undefined/Unknown",
volume = "81",
pages = "103--122",
journal = "Critical Reviews in Oncology / Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice. / Giovannetti, E.; Erozenci, A.; Smit, J.; Danesi, R.; Peters, G.J.

In: Critical Reviews in Oncology / Hematology, Vol. 81, No. 2, 2012, p. 103-122.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

AU - Giovannetti, E.

AU - Erozenci, A.

AU - Smit, J.

AU - Danesi, R.

AU - Peters, G.J.

PY - 2012

Y1 - 2012

U2 - 10.1016/j.critrevonc.2011.03.010

DO - 10.1016/j.critrevonc.2011.03.010

M3 - Article

VL - 81

SP - 103

EP - 122

JO - Critical Reviews in Oncology / Hematology

JF - Critical Reviews in Oncology / Hematology

SN - 1040-8428

IS - 2

ER -